×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
XLO – xilio therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
XLO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
07:50 am
xlo
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI [Yahoo! Finance]
Medium
Report
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI [Yahoo! Finance]
12/19
07:30 am
xlo
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
Medium
Report
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
12/16
07:47 am
xlo
Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer [Yahoo! Finance]
Medium
Report
Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer [Yahoo! Finance]
12/16
07:30 am
xlo
Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer
Medium
Report
Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer
12/9
11:58 am
xlo
After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright [Yahoo! Finance]
Low
Report
After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright [Yahoo! Finance]
12/3
04:38 pm
xlo
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
12/3
04:30 pm
xlo
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/8
01:44 pm
xlo
Xilio Therapeutics, Inc. (NASDAQ: XLO) had its price target lowered by analysts at Raymond James from $6.00 to $4.00. They now have an "outperform" rating on the stock.
Low
Report
Xilio Therapeutics, Inc. (NASDAQ: XLO) had its price target lowered by analysts at Raymond James from $6.00 to $4.00. They now have an "outperform" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/19
04:20 pm
xlo
Form 4 Xilio Therapeutics, Inc. For: Dec 18 Filed by: GILEAD SCIENCES, INC.
High
Report
Form 4 Xilio Therapeutics, Inc. For: Dec 18 Filed by: GILEAD SCIENCES, INC.
12/19
04:16 pm
xlo
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: GILEAD SCIENCES, INC.
High
Report
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: GILEAD SCIENCES, INC.
12/19
07:46 am
xlo
Form 8-K Xilio Therapeutics, Inc. For: Dec 18
Medium
Report
Form 8-K Xilio Therapeutics, Inc. For: Dec 18
11/14
05:44 pm
xlo
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
High
Report
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
11/14
04:31 pm
xlo
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Medium
Report
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
11/12
04:51 pm
xlo
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Rock Springs Capital Management LP
Medium
Report
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Rock Springs Capital Management LP
11/12
10:41 am
xlo
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: FMR LLC
Low
Report
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: FMR LLC
11/7
09:26 am
xlo
Form 10-Q Xilio Therapeutics, Inc. For: Sep 30
High
Report
Form 10-Q Xilio Therapeutics, Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: